References
- Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. [Internet]. 1996 [cited 2018 Nov 4];80:389–393. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8695555
- Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. [Internet]. 1997 [cited 2018 Nov 4];38:83–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9008633
- Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. [Internet]. 2006 [cited 2018 Nov 4];90:262–267. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16488940
- Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. [Internet]. 2004 [cited 2018 Nov 4];363:1711–1720. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673604162570
- Wong MOM, Lee JWY, Choy BNK, et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol. [Internet]. 2015 [cited 2018 Nov 4];60:36–50. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0039625714001313
- Beckman H, Meinert CL, Ritch R, et al. The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group. Ophthalmology. [Internet]. 1990 [cited 2018 Nov 4];97:1403–1413. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2255512
- Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. [Internet]. 1995 [cited 2018 Nov 4];60:359–371. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7789416
- Hann CR, Fautsch MP. Preferential fluid flow in the human trabecular meshwork near collector channels. Invest Ophthalmol Vis Sci. 2009 [cited 2018 Nov 4];50:1692–1697. [Internet]. Available from.
- Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. [Internet]. 1983 [cited 2018 Nov 4];220:524–527. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6836297
- Li X, Wang W, Zhang X. Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. BMC Ophthalmol. [Internet]. 2015 [cited 2018 Nov 4];15:107. Available from: http://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-015-0091-2
- Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol. (Chicago, Ill. 1960) [Internet]. 2003 [cited 2018 Nov 4];121:957–960. Available from:
- Schlote T, Kynigopoulos M. Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma. Int Ophthalmol. [Internet]. 2016 [cited 2018 Nov 4];36:55–61. Available from: http://link.springer.com/10.1007/s10792-015-0079-1
- Kerr NM, Lew HR, Skalicky SE. Selective laser trabeculoplasty reduces intraocular pressure peak in response to the water drinking test. J Glaucoma. [Internet]. 2016 [cited 2018 Nov 4];25:727–731. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00061198-201609000-00004
- Association for Research in Vision and Ophthalmology. SA, McGlynn RH, George MK, et al. Investigative ophthalmology & visual science. [Internet]. Invest Ophthalmol Vis Sci. [Association for Research in Vision and Ophthalmology, etc.]; 2006 [cited 2018 Nov 4]. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2395251
- Shibata M, Sugiyama T, Ishida O, et al. Clinical results of selective laser trabeculoplasty in open-angle glaucoma in Japanese eyes: comparison of 180 degree with 360 degree SLT. J Glaucoma. [Internet]. 2012 [cited 2018 Nov 4];21:17–21. Available from: https://insights.ovid.com/crossref?an=00061198-201201000-00004
- Nagar M, Ogunyomade A, O’Brart DPS, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol. [Internet]. 2005 [cited 2018 Nov 4];89:1413–1417. Available from: http://bjo.bmj.com/cgi/doi/10.1136/bjo.2004.052795
- Association for Research in Vision and Ophthalmology. AR, Hughes BA, Juzych MS, et al. Investigative ophthalmology & visual science. [Internet]. Invest Ophthalmol Vis Sci. [Association for Research in Vision and Ophthalmology, etc.]. 2005 [cited 2018 Nov 4]. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2399552
- Prasad N, Murthy S, Dagianis JJ, et al. A comparison of the intervisit intraocular pressure fluctuation after 180 and 360 degrees of selective laser trabeculoplasty (SLT) as a primary therapy in primary open angle glaucoma and ocular hypertension. J Glaucoma. [Internet]. 2009 [cited 2018 Nov 4];18:157–160. Available from: https://insights.ovid.com/crossref?an=00061198-200902000-00013
- Onakoya AO, Olowoyeye AO, Onyekwelu OMA, et al. Intraocular pressure changes post selective laser trabeculoplasty in the contralateral untreated eyes of nigerian patients with primary open angle glaucoma. Nig Q J Hosp Med. [Internet]. [cited 2018 Nov 4];25:133–138. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27295834
- Gulati V, Fan S, Gardner BJ, et al. Mechanism of action of selective laser trabeculoplasty and predictors of response. Invest Ophthalmol Vis Sci. [Internet]. 2017 [cited 2018 Nov 4];58:1462–1468. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.16-20710
- Latina MA, Gulati V. Selective laser trabeculoplasty: stimulating the meshwork to mend its ways. Int Ophthalmol Clin. [Internet]. 2004 [cited 2018 Nov 4];44:93–103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14704524
- Kara N, Altan C, Satana B, et al. Comparison of selective laser trabeculoplasty success in patients treated with either prostaglandin or timolol/dorzolamide fixed combination. J Ocul Pharmacol Ther. [Internet]. 2011 [cited 2018 Nov 4];27:339–342. Available from: http://www.liebertpub.com/doi/10.1089/jop.2011.0015
- Ayala M, Chen E. The influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment. J Ocul Pharmacol Ther. [Internet]. 2012 [cited 2018 Nov 4];28:118–122. Available from: http://www.liebertpub.com/doi/10.1089/jop.2011.0084
- Matos AG, Asrani SG, Paula JS. Feasibility of laser trabeculoplasty in angle closure glaucoma: a review of favourable histopathological findings in narrow angles. Clin Experiment Ophthalmol. [Internet]. 2017 [cited 2018 Nov 4];45:632–639. Available from: http://doi.wiley.com/10.1111/ceo.12938
- Hamanaka T, Kasahara K, Takemura T. Histopathology of the trabecular meshwork and Schlemm’s canal in primary angle-closure glaucoma. Invest Ophthalmol Vis Sci. [Internet]. 2011 [cited 2018 Nov 4];52:8849–8861. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21960557
- Garcés Fernández A, Piloto Díaz I, Miqueli Rodríguez M, et al. Revista Cubana de Oftalmologia. Rev Cuba Oftalmol. [Internet]. 2010[cited 2018 Nov 4]; Centro Nacional de Informacion de Ciencias Medicas Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762010000100003
- Narayanaswamy A, Leung CK, Istiantoro DV, et al. Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial. [Internet] JAMA Ophthalmol. 2015 [cited 2018 Nov 4];133:206–212. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/jamaophthalmol.2014.4893
- Ho CL, Lai JSM, Aquino MV, et al. Selective laser trabeculoplasty for primary angle closure with persistently elevated intraocular pressure after iridotomy. J Glaucoma. [Internet]. 2009 [cited 2018 Nov 4];18:563–566. Available from: https://insights.ovid.com/crossref?an=00061198-200909000-00011
- Tzimis V, Tze L, Ganesh J, et al. Laser trabeculoplasty: an investigation into factors that might influence outcomes. Can J Ophthalmol. [Internet]. 2011 [cited 2018 Nov 4];46:305–309. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0008418211000445
- Ayala M, Chen E. Comparison of selective laser trabeculoplasty (SLT) in primary open angle glaucoma and pseudoexfoliation glaucoma. Clin Ophthalmol. [Internet]. 2011 [cited 2018 Nov 4];5:1469–1473. Available from: http://www.dovepress.com/comparison-of-selective-laser-trabeculoplasty-slt-in-primary-open-angl-peer-reviewed-article-OPTH
- Kent SS, Hutnik CML, Birt CM, et al. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation. J Glaucoma. [Internet]. 2015 [cited 2018 Nov 4];24:344–347. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00061198-201506000-00002
- Wang H, Cheng JW, Wei RL, et al. Meta-analysis of selective laser trabeculoplasty with argon laser trabeculoplasty in the treatment of open-angle glaucoma. Can J Ophthalmol. [Internet]. 2013 [cited 2018 Nov 4];48:186–192. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0008418213000021
- Polat J, Grantham L, Mitchell K, et al. Repeatability of selective laser trabeculoplasty. Br J Ophthalmol. [Internet]. 2016 [cited 2018 Nov 4];100:1437–1441. Available from: http://bjo.bmj.com/lookup/doi/10.1136/bjophthalmol-2015-307486
- Richter CU, Shingleton BJ, Bellows AR, et al. Retreatment with argon laser trabeculoplasty. Ophthalmology. [Internet]. 1987 [cited 2018 Nov 4];94:1085–1089. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3684226
- Wang W, He M, Zhou M, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with open-angle glaucoma: a systematic review and meta-analysis. PLoS One. Vavvas D, editor. 2013 [cited 2018 Nov 4];8:e84270 [Internet] Available from: https://dx.plos.org/10.1371/journal.pone.0084270
- Damji KF, Bovell AM, Hodge WG, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol. [Internet]. 2006 [cited 2018 Nov 4];90:1490–1494. Available from: http://bjo.bmj.com/cgi/doi/10.1136/bjo.2006.098855
- Hong BK, Winer JC, Martone JF, et al. Repeat selective laser trabeculoplasty. J Glaucoma. [Internet]. 2009 [cited 2018 Nov 4];18:180–183. Available from: https://insights.ovid.com/crossref?an=00061198-200903000-00002
- Avery N, Ang GS, Nicholas S, et al. Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma. Int Ophthalmol. [Internet]. 2013 [cited 2018 Nov 4];33:501–506. Available from: http://link.springer.com/10.1007/s10792-013-9729-3
- Hutnik Cindy C, Crichton A, Ford B, et al. SLT versus ALT in glaucoma patients treated previously with 360-degree SLT:A randomized, single-blind, equivalence clinical trial. Ophthalmology. [Internet]. 2018. [cited 2018 Nov 4]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S016164201831563X
- Francis BA, Loewen N, Hong B, et al. Repeatability of selective laser trabeculoplasty for open-angle glaucoma. BMC Ophthalmol. [Internet]. 2016 [cited 2018 Nov 4];16:128. Available from: http://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-016-0299-9
- Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT. Health Technol Assess (Rockv). 2019;23:1–101.
- Lee R, Hutnik CML. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol. [Internet]. 2006 [cited 2018 Nov 4];41:449–456. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0008418206800062
- Seider MI, Keenan JD, Han Y. Cost of selective laser trabeculoplasty vs topical medications for glaucoma. Arch Ophthalmol. 2012 cited 2018 Nov 4;130:529–530. (Chicago, Ill. 1960) [Internet]. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archophthalmol.2012.355
- Lamoureux EL, Mcintosh R, Constantinou M, et al. Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial. Trials. [Internet]. 2015 [cited 2018 Nov 4];16:406. Available from: http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0924-6
- Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. [Internet]. 2018 [cited 2018 Nov 4];102:593–598. Available from: http://bjo.bmj.com/lookup/doi/10.1136/bjophthalmol-2017-310877
- Association for Research in Vision and Ophthalmology. DD, Krishna R, Willoughby L. Investigative ophthalmology & visual science. [Internet]. Invest Ophthalmol Vis Sci. [Association for Research in Vision and Ophthalmology, etc.]; 2005 [cited 2018 Nov 4]. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2399559
- Abramowitz B, Chadha N, Kouchouk A, et al. Selective laser trabeculoplasty vs micropulse laser trabeculoplasty in open-angle glaucoma. Clin Ophthalmol. [Internet]. 2018 [cited 2018 Nov 4];12:1599–1604. Available from: https://www.dovepress.com/selective-laser-trabeculoplasty-vs-micropulse-laser-trabeculoplasty-in-peer-reviewed-article-OPTH
- Kaplowitz K, Wang S, Bilonick R, et al. Randomized Controlled Comparison of Titanium-Sapphire Versus Standard Q-Switched Nd. J Glaucoma. [Internet]. 2016 [cited 2019 Sep 2];25:e663–e667. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26325273
- Tsang S, Cheng J, Lee JW. Developments in laser trabeculoplasty: table 1. Br J Ophthalmol. [Internet]. 2016 [cited 2019 Sep 2];100:94–97. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26377417
- Ekici F, Waisbourd M, Katz LJ. Current and future of laser therapy in the management of glaucoma. Open Ophthalmol J. [Internet]. 2016 [cited 2019 Sep 2];10:56–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27014388
- Mansouri K, Shaarawy T. Comparing pattern scanning laser trabeculoplasty to selective laser trabeculoplasty: A randomized controlled trial. Acta Ophthalmol. [Internet]. 2017 [cited 2019 Sep 2];95:e361–e365. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27778483
- BERENS C. Glaucoma surgery; an evaluation of cycloelectrolysis and cyclodiathermy. AMA Arch Ophthalmol. [Internet]. 1955 [cited 2018 Nov 4];54:548–563. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13257985
- Hampton C, Shields MB, Miller KN, et al. Evaluation of a protocol for transscleral neodymium: YAG cyclophotocoagulation in one hundred patients. Ophthalmology. [Internet]. 1990 [cited 2018 Nov 4];97:910–917. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2381706
- Scheie HG, Frayer WC, Spencer RW. Cyclodiathermy; a clinical and tonographic evaluation. AMA Arch Ophthalmol. [Internet]. 1955 [cited 2018 Nov 4];53:839–846. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14375442
- Peyman GA, Naguib KS, Gaasterland D. Trans-scleral application of a semiconductor diode laser. Lasers Surg Med. [Internet]. 1990 [cited 2018 Nov 4];10:569–575. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2263156
- Bloom PA, Tsai JC, Sharma K, et al. Cyclodiode. Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology. [Internet]. 1997[cited 2018 Nov 4];104:1508–1519 discussion 1519–20 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9307649
- Vernon SA, Koppens JM, Menon GJ, et al. Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature. [Internet] Clin Experiment Ophthalmol. 2006; [cited 2018 Nov 4];34:411–420. Available from: http://doi.wiley.com/10.1111/j.1442-9071.2006.01241.x
- Zhekov I, Janjua R, Shahid H, et al. A retrospective analysis of long-term outcomes following a single episode of transscleral cyclodiode laser treatment in patients with glaucoma. BMJ Open. [Internet]. 2013 [cited 2018 Nov 4];3:e002793. Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2013-002793
- Murphy CC, Burnett CAM, Spry PGD, et al. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. [Internet]. 2003 [cited 2018 Nov 4];87:1252–1257. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14507761
- Ramli N, Htoon HM, Ho CL, et al. Risk factors for hypotony after transscleral diode cyclophotocoagulation. J Glaucoma. [Internet]. 2012 [cited 2018 Nov 4];21:169–173. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00061198-201203000-00007
- Yap-Veloso MI, Simmons RB, Echelman DA, et al. Intraocular pressure control after contact transscleral diode cyclophotocoagulation in eyes with intractable glaucoma. J Glaucoma. [Internet]. 1998 [cited 2018 Nov 4];7:319–328. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9786561
- Ansari E, Gandhewar J. Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma. Eye (Lond). [Internet]. 2007 [cited 2018 Nov 4];21:936–940. Available from: http://www.nature.com/articles/6702345
- Walland MJ. Diode laser cyclophotocoagulation: longer term follow up of a standardized treatment protocol. Clin Exp Ophthalmol. [Internet]. 2000 [cited 2018 Nov 4];28:263–267. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11021554
- Ishida K. Update on results and complications of cyclophotocoagulation. Curr Opin Ophthalmol. [Internet]. 2013 [cited 2018 Nov 4];24:102–110. Available from: https://insights.ovid.com/crossref?an=00055735-201303000-00004
- Uram M. Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma. Ophthalmology. [Internet]. 1992 [cited 2018 Nov 4];99:1823–1828. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1480398
- Falkenberry SM, Siegfried CJ. Endocyclophotocoagulation. Middle East Afr J Ophthalmol. [Internet]. 2009 [cited 2018 Nov 4];16:130–133. Available from: http://www.meajo.org/text.asp?2009/16/3/130/56225
- Yang Y, Zhong J, Dun Z, et al. Comparison of efficacy between endoscopic cyclophotocoagulation and alternative surgeries in refractory glaucoma: a meta-analysis. Medicine (Baltimore). [Internet]. 2015 [cited 2018 Nov 4];94:e1651. Available from: https://insights.ovid.com/crossref?an=00005792-201509050-00059.
- Lima FE, Magacho L, Carvalho DM, et al. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma. [Internet]. 2004 [cited 2018 Nov 4];13:233–237. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15118469
- Rathi S, Radcliffe NM. Combined endocyclophotocoagulation and phacoemulsification in the management of moderate glaucoma. Surv Ophthalmol. [Internet]. 2017 [cited 2018 Nov 4];62:712–715. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0039625715300400
- Lima FEL, Carvalho DMD, Avila MPD. [Phacoemulsification and endoscopic cyclophotocoagulation as primary surgical procedure in coexisting cataract and glaucoma]. Arq Bras Oftalmol. [Internet]. [cited 2018 Nov 4]; 73:419–422. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21225125
- Berke SJ. Endolaser cyclophotocoagulation in glaucoma management. Tech Ophthalmol. [Internet]. 2006 [cited 2018 Nov 4];4:74–81. Available from: https://insights.ovid.com/crossref?an=00145756-200606000-00008
- Lin SC, Chen MJ, Lin MS, et al. Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation. Br J Ophthalmol. [Internet]. 2006 [cited 2018 Nov 4];90:496–500. Available from: http://bjo.bmj.com/cgi/doi/10.1136/bjo.2005.072777
- Clement CI, Kampougeris G, Ahmed F, et al. Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma. Clin Experiment Ophthalmol. [Internet]. 2013 [cited 2019 Jan 9];41:546–551. Available from.
- Chen J, Cohn RA, Lin SC, et al. Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol. [Internet]. 1997 [cited 2018 Nov 4];124:787–796. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9402825
- Tan AM, Chockalingam M, Aquino MC, et al. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. [Internet] Clin Exp Ophthalmol. 2010; [cited 2018 Nov 4];38:266–272. . Available from
- Aquino MCD, Barton K, Tan AMWT, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Experiment Ophthalmol. [Internet] 2015[cited 2018 Nov 4];43:40–46. Available from: http://doi.wiley.com/10.1111/ceo.12360
- Emanuel ME, Grover DS, Fellman RL, et al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma. [Internet]. 2017 [cited 2018 Nov 4];26:726–729. Available from: http://insights.ovid.com/crossref?an=00061198-201708000-00009
- Kuchar S, Moster MR, Reamer CB, et al. Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci. [Internet]. 2016 [cited 2018 Nov 4];31:393–396. Available from: http://link.springer.com/10.1007/s10103-015-1856-9
- Yelenskiy A, Gillette TB, Arosemena A, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. [Internet]. 2018 [cited 2018 Nov 4];27:920–925. Available from: http://insights.ovid.com/crossref?an=00061198-900000000-98391
- Bar-David L, Blumenthal EZ. Evolution of glaucoma surgery in the last 25 years. Rambam Maimonides Med J. 2018;9:e0024.
- Coleman AL. Advances in glaucoma treatment and management: surgery. Invest Ophthalmol Vis Sci. 2012;53:2491–2494.
- Masoumpour MB, Nowroozzadeh MH, Razeghinejad MR. Current and future techniques in wound healing modulation after glaucoma filtering surgeries. Open Ophthalmol J. 2016;10:68–85.
- Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol. 1999;10:112–116.
- Broadway D, Grierson I, Hitchings R. Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important? Br J Ophthalmol. 1994;78:466–475.
- Issa de Fendi L, Cena de Oliveira T, Bigheti Pereira C, et al. Additive effect of risk factors for trabeculectomy failure in glaucoma patients. J Glaucoma. 2016;25:e879–e883.
- Landers J, Martin K, Sarkies N, et al. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119:694–702.
- Lavin MJ, Wormald RP, Migdal CS, et al. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990;108:1543–1548.
- Khaw PT, Chiang M, Shah P, et al. Enhanced trabeculectomy - The Moorfields safer surgery system. Dev Ophthalmol. 2012;50:1–28.
- Husain R, Liang S, Foster PJ, et al. Cataract surgery after trabeculectomy. Arch Ophthalmol. 2012;130:165.
- Musch DC, Lichter PR, Guire KE, et al. The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. [Internet]. 1999 [cited 2019 Jan 9];106:653–662. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10201583
- AGIS (Advanced Glaucoma Intervention Study) Investigators. The advanced glaucoma intervention study: 8. risk of cataract formation after trabeculectomy. Arch Ophthalmol. (Chicago, Ill. 1960) [Internet]. 2001 [cited 2019 Jan 9];119:1771–1779. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11735786
- Adelman RA, Brauner SC, Afshari NA, et al. Cataract formation after initial trabeculectomy in young patients. Ophthalmology. [Internet]. 2003 [cited 2019 Jan 9];110:625–629. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0161642002017694
- Musch DC, Gillespie BW, Niziol LM, et al. Cataract extraction in the collaborative initial glaucoma treatment study. Arch Ophthalmol. [Internet]. 2006 [cited 2019 Jan 9];124:1694. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17159028
- Aykan U, Bilge AH, Akin T, et al. Laser suture lysis or releasable sutures after trabeculectomy. J Glaucoma. 2007;16:240–245.
- Wells AP, Bunce C, Khaw PT. Flap and suture manipulation after trabeculectomy with adjustable sutures: titration of flow and intraocular pressure in guarded filtration surgery. J Glaucoma. 2004;13:400–406.
- Jones E, Clarke J, Khaw PT. Recent advances in trabeculectomy technique. Curr Opin Ophthalmol. 2005;16:107–113.
- Dhingra S, Khaw PT. The moorfields safer surgery system. Middle East Afr J Ophthalmol. [Internet]. 2009 [cited 2019 Jan 9];16:112–115. Available from: http://www.meajo.org/text.asp?2009/16/3/112/56220
- Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;(4):CD002897. Published 2005 Oct 19. doi:10.1002/14651858.CD002897.pub2
- Wormald R, Wilkins MR, Bunce C. Post-operative 5-Fluorouracil for glaucoma surgery. Cochrane Database Syst Rev. 2001;(3):CD001132. doi:10.1002/14651858.CD001132
- Cabourne E, Clarke JC, Schlottmann PG, et al. Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev. 2015;(11):CD006259. Published 2015 Nov 6. doi:10.1002/14651858.CD006259.pub2
- Green E, Wilkins M, Bunce C, et al. 5-Fluorouracil for glaucoma surgery. Cochrane Database Syst Rev. 2014;(2):CD001132. Published 2014 Feb 19. doi:10.1002/14651858.CD001132.pub2
- Seibold LK, Sherwood MB, Kahook MY. Wound modulation after filtration surgery. Surv Ophthalmol. 2012;57:530–550.
- Almatlouh A, Bach-Holm D, Kessel L. Steroids and nonsteroidal anti-inflammatory drugs in the postoperative regime after trabeculectomy – which provides the better outcome? A systematic review and meta-analysis. Acta Ophthalmol. 2019;97:146–157.
- Breusegem C, Spielberg L, Van Ginderdeuren R, et al. Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy. Ophthalmology. 2010;117:1324–1330.
- Starita RJ, Fellman RL, Spaeth GL, et al. Short- and long-term effects of postoperative corticosteroids on trabeculectomy. Ophthalmology. 1985;92:938–946.
- Azuara-Blanco A, Spaeth GL, Augsburger JJ. Oral prednisone in guarded filtration procedures supplemented with antimetabolites. Ophthalmic Surg Lasers. 1999;30:126–132.
- Constable PH, Crowston JG, Occleston NL, et al. Long term growth arrest of human Tenon’s fibroblasts following single applications of beta radiation. Br J Ophthalmol. 1998;82:448–452.
- Li Z, Van Bergen T, Van de Veire S, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009;50:5217–5225.
- Coote MA, Ruddle JB, Qin Q, et al. Vascular changes after intra-bleb injection of bevacizumab. J Glaucoma. 2008;17:517–518.
- Kahook MY, Schuman JS, Noecker RJ. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imaging. 2006;37:148–150.
- Cornish KS, Ramamurthi S, Saidkasimova S, et al. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients. Eye. 2009;23:979–981.
- Grewal DS, Jain R, Kumar H, et al. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology. 2008;115:2141–2145.e2.
- Sung MS, Eom GH, Kim SJ, et al. Trichostatin a ameliorates conjunctival fibrosis in a rat trabeculectomy model. Investig Ophthalmol Vis Sci. 2018;59:3115–3123.
- Shaffer RN, Hetherington J, Hoskins HD. Guarded thermal sclerostomy. Am J Ophthalmol. 1971;72:769–772.
- Zhou M, Wang W, Huang W, et al. Trabeculectomy with versus without releasable sutures for glaucoma: a meta-analysis of randomized controlled trials. BMC Ophthalmol. 2014;14:41.
- Angmo D, Wadhwani M, Upadhyay AD, et al. Outcomes of trabeculectomy augmented with subconjunctival and subscleral ologen implantation in primary advanced glaucoma. J Glaucoma. 2017;26:8–14.
- Shihadeh W, Massad I, Khader Y, et al. Comparison of the outcomes of trabeculectomy with 5-fluorouracil versus ologen implant in primary open-angle glaucoma. Ophthalmic Res. 2017;58:94–98.
- Senthil S, Rao HL, Babu JG, et al. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma. Indian J Ophthalmol. 2013;61:338–342.
- Furino C, Boscia F, Cicinelli MV, et al. Subconjunctival sustained-release dexamethasone implant as an adjunct to trabeculectomy for primary open angle glaucoma. Indian J Ophthalmol. 2016;64:251–252. Medknow Publications.
- Clement CI, Goldberg I. The management of complicated glaucoma. Indian J Ophthalmol. 2011;59(Suppl):S141–7.
- Tseng VL, Coleman AL, Chang MY, et al. Aqueous shunts for glaucoma. Cochrane Database Syst Rev. 2017;7(7):CD004918. Published 2017 Jul 28. doi:10.1002/14651858.CD004918.pub3
- Christakis PG, Zhang D, Budenz DL, et al. Five-year pooled data analysis of the ahmed baerveldt comparison study and the ahmed versus baerveldt study. Am J Ophthalmol. 2017;176:118–126.
- Pimentel E, Schmidt J. Is Ahmed valve superior to Baerveldt implant as an aqueous shunt for the treatment of glaucoma? Medwave. 2018;18:e7239.
- HaiBo T, Xin K, ShiHeng L, et al. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis. Acott TS, editor. PLoS One. 2015;10:e0118142.
- Islamaj E, Wubbels RJ, de Waard PWT. Primary Baerveldt versus trabeculectomy study after one-year follow-up. Acta Ophthalmol. 2018;96:e740–e746.
- Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153:789–803.e2.
- Gedde SJ, Schiffman JC, Feuer WJ, et al. The tube versus trabeculectomy study: design and baseline characteristics of study patients. Am J Ophthalmol. [Internet]. 2005 [cited 2019 Jan 9];140:275–287. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0002939405003272
- Gedde SJ, Feuer WJ, Shi W, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology. [Internet] 2018[cited 2019 Jan 15];125:650–663. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29477688
- Yalvac IS, Sahin M, Eksioglu U, et al. Primary viscocanalostomy versus trabeculectomy for primary open-angle glaucoma. J Cataract Refract Surg. [Internet]. 2004 [cited 2019 Jan 16];30:2050–2057. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15474813
- O’Brart DPS, Shiew M, Edmunds B. A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol. [Internet]. 2004 [cited 2019 Jan 16];88:1012–1017. Available from: http://bjo.bmj.com/cgi/doi/10.1136/bjo.2003.037432
- O’Brart DPS, Rowlands E, Islam N, et al. A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol. [Internet]. 2002 [cited 2019 Jan 16];86:748–754. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12084743
- Kobayashi H, Kobayashi K. Randomized comparison of the intraocular pressure–lowering effect of phacoviscocanalostomy and phacotrabeculectomy. Ophthalmology. [Internet]. 2007 [cited 2019 Jan 16];114:909–914. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17397924.
- Carassa RG, Bettin P, Fiori M, et al. Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial. Ophthalmology. [Internet]. 2003 [cited 2019 Jan 16];110:882–887. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0161642003000812
- El Sayyad F, Helal M, El-Kholify H, et al. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology. [Internet]. 2000 [cited 2019 Jan 16];107:1671–1674. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10964827
- Dahan E, Drusedau MU. Nonpenetrating filtration surgery for glaucoma: control by surgery only. J Cataract Refract Surg. [Internet]. 2000 cited 2019 Jan 16;26:695–701. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10831899
- Sarodia U, Shaarawy T, Barton K. Nonpenetrating glaucoma surgery: a critical evaluation. Curr Opin Ophthalmol. [Internet]. 2007 [cited 2019 Jan 16];18:152–158. Available from: https://insights.ovid.com/crossref?an=00055735-200703000-00011
- Mendrinos E, Mermoud A, Shaarawy T. Nonpenetrating glaucoma surgery. Surv Ophthalmol. [Internet]. 2008 [cited 2019 Jan 16];53:592–630. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0039625708001483
- Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN, et al. Nonpenetrating deep sclerectomy: a 6-year retrospective study. Eur J Ophthalmol. [Internet]. [cited 2019 Jan 16];14:26–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15005582
- Demailly P, Lavat P, Kretz G, et al. Non-penetrating deep sclerectomy (NPDS) with or without collagen device (CD) in primary open-angle glaucoma: middle-term retrospective study. Int Ophthalmol. [Internet]. [cited 2019 Jan 16];20:131–140. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9112177
- Hamard P, Lachkar Y. [Non penetrating filtering surgery, evolution and results]. J Fr Ophtalmol. [Internet]. 2002 [cited 2019 Jan 16];25:527–536. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12048520
- Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. [Internet]. 1999 [cited 2019 Jan 16];25:316–322. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10079435
- Lüke C, Dietlein TS, Jacobi PC, et al. A prospective randomised trial of viscocanalostomy with and without implantation of a reticulated hyaluronic acid implant (SKGEL) in open angle glaucoma. Br J Ophthalmol. [Internet]. 2003 [cited 2019 Jan 16];87:599–603. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12714403
- Yarangümeli A, Köz OG, Alp MN, et al. Viscocanalostomy with mitomycin-C: a preliminary study. Eur J Ophthalmol. [Internet]. [cited 2019 Jan 16];15:202–208. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15812760
- Netland PA, Sarkisian SR, Moster MR, et al. Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study). Am J Ophthalmol. 2014;157:433–440.e3.
- Dahan E, Ben Simon GJ, Lafuma A. Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: a prospective, randomised study. Eye. 2012;26:703–710.
- Wagschal LD, Trope GE, Jinapriya D, et al. Prospective randomized study comparing Ex-PRESS to trabeculectomy. J Glaucoma. 2015;24:624–629.
- Beltran-Agullo L, Trope GE, Jin Y, et al. Comparison of visual recovery following Ex-PRESS versus trabeculectomy. J Glaucoma. 2015;24:181–186.
- de Jong LAMS. The Ex-PRESS glaucoma shunt versus trabeculectomy in open-angle glaucoma: a prospective randomized study. Adv Ther. 2009;26:336–345.
- De Jong L, Lafuma A, Aguadé AS, et al. Five-year extension of a clinical trial comparing the EX-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma. Clin. Ophthalmol. 2011;5:527–533.
- Chen PP, Lin SC, Junk AK, et al. The effect of phacoemulsification on intraocular pressure in glaucoma patients: a report by the american academy of ophthalmology. Ophthalmology. 2015;122:1294–1307.
- Shingleton BJ, Pasternack JJ, Hung JW, et al. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006;15:494–498.
- Azuara-Blanco A, Burr J, Ramsay C, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet. 2016;388:1389–1397.
- Tanito M, Matsuo M. Ab-interno trabeculotomy-related glaucoma surgeries. Taiwan J Ophthalmol. 2019;9:67–71. Wolters Kluwer Medknow Publications.
- Bao W, Kawase K, Huang H, et al. The long-term outcome of trabeculotomy: Comparison with filtering surgery in Japan. BMC Ophthalmol. 2019;19:99.
- Francis BA, Singh K, Lin SC, et al. Novel glaucoma procedures: a report by the American academy of ophthalmology. Ophthalmology. [Internet]. 2011 [cited 2018 Nov 4];118:1466–1480. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21724045
- Caprioli J, Kim JH, Friedman DS, et al. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery. Ophthalmology. [Internet]. 2015 [cited 2018 Nov 4];122:1795–1801. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0161642015001712
- Coleman AL, Richter G. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. [Internet]. 2016 cited 2018 Nov 4;10:189. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26869753
- Craven ER, Katz LJ, Wells JM, et al. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. [Internet]. 2012 [cited 2018 Nov 5];38:1339–1345. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22814041
- Neuhann TH. Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: long-term results. J Cataract Refract Surg. [Internet]. 2015 [cited 2018 Nov 4];41:2664–2671. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26796447
- Giamporcaro JE, Katz LJ, Erb C, et al. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol. [Internet]. 2015 [cited 2018 Nov 4];9:2313. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26715834
- Voskanyan L, García-Feijoó J, Belda JI, et al. Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial. Adv Ther. [Internet] 2014[cited 2018 Nov 4];31:189–201. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24452726
- Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. A randomized trial of a schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. [Internet]. 2015 [cited 2018 Nov 4];122:1283–1293. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25972254
- Vold S, Ahmed IIK, Craven ER, et al. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology. [Internet]. 2016 [cited 2018 Nov 4];123:2103–2112. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27506486
- Preliminary ASCRS CyPass Withdrawal Consensus Statement | ASCRS [Internet]. [cited 2018 Nov 4]. Available from: http://ascrs.org/CyPass_Statement.
- Hoeh H, Ahmed IIK, Grisanti S, et al. Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open-angle glaucoma concomitant with cataract surgery. J Cataract Refract Surg. [Internet]. 2013 [cited 2018 Nov 4];39:431–437. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23506920
- Höh H, Grisanti S, Grisanti S, et al. Two-year clinical experience with the cypass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monbl Augenheilkd. [Internet]. 2014 [cited 2018 Nov 4];231:377–381. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24771171.
- García-Feijoo J, Rau M, Grisanti S, et al. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol. [Internet]. 2015 [cited 2018 Nov 4];159:1075–1081.e1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25747677
- Myers JS, Masood I, Hornbeak DM, et al. Prospective evaluation of two iStent® trabecular stents, one iStent Supra® suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes. Adv Ther. [Internet]. 2018 [cited 2020 Jan 1];35:395–407. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29476443
- Tanito M, Chihara E. Safety and effectiveness of gold glaucoma micro shunt for reducing intraocular pressure in Japanese patients with open angle glaucoma. Jpn J Ophthalmol. [Internet]. 2017 [cited 2020 Jan 1];61:388–394. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28600745
- Lewis RA. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg. [Internet]. 2014 [cited 2018 Nov 4];40:1301–1306. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24943904
- Sheybani A, Lenzhofer M, Hohensinn M, et al. Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: pilot study. J Cataract Refract Surg. [Internet]. 2015 [cited 2019 Mar 12];41:1905–1909. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0886335015010391
- Sheybani A, Dick HB, Ahmed IIK. Early clinical results of a novel Ab interno gel stent for the surgical treatment of open-angle glaucoma. J Glaucoma. [Internet]. 2016 [cited 2019 Mar 13];25:e691–e696. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26561420
- Smith M, Charles R, Abdel-Hay A, et al. 1-year outcomes of the Xen45 glaucoma implant. Eye. [Internet]. 2018. [cited 2019 Jan 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30552422
- Batlle JF, Fantes F, Riss I, et al. Three-year follow-up of a novel aqueous humor microShunt. J Glaucoma. [Internet] 2016 [cited 2018 Nov 4];25:e58–e65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26766400